NSB — Neuroscientific Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Neuroscientific Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7.22	4.91	4.95	7.27	4.63
Net Total Accounts Receivable
Net Total Receivables	0.121	0.043	0.054	0.098	0.128
Prepaid Expenses
Total Current Assets	7.4	5.01	5.04	7.4	4.8
Net Property, Plant And Equipment	0.017	0.009	0.006	0.001	0.087
Net Intangible Assets
Long Term Investments
Total Assets	7.74	5.29	5.44	17	15.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.22	0.597	0.086	0.149	0.336
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	2.22	0.597	0.086	0.149	0.375
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	5.52	4.69	5.35	16.8	14.8
Total Liabilities & Shareholders' Equity	7.74	5.29	5.44	17	15.2
Total Common Shares Outstanding